Evidence map›Paper›PMID 25229165›Full record

ArticleClinical immunology (Orlando, Fla.)2014

In utero arsenic exposure and fetal immune repertoire in a US pregnancy cohort.

Kari C Nadeau, Zhigang Li, Shohreh Farzan, Devin Koestler, David Robbins, Dennis Liang Fei, Meena Malipatlolla, Holden Maecker, Richard Enelow, Susan Korrick and 1 more

Open access · greenAbstract read
In one paragraph

Article in Clinical immunology (Orlando, Fla.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 2 pooled it
9.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 2 syntheses or guidelines pooled it, 83 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Kari C NadeauDivision of Immunology and Allergy, Stanford University, 730 Welch Road, Stanford, CA, USA. Electronic address: Knadeau@stanford.edu.
Zhigang LiGeisel School of Medicine at Dartmouth, 1 Rope Ferry Road, Hanover, NH 03755, USA. Electronic address: Zhigang.Li@Dartmouth.edu.
Shohreh FarzanGeisel School of Medicine at Dartmouth, 1 Rope Ferry Road, Hanover, NH 03755, USA. Electronic address: Shohreh.F.Farzan@Dartmouth.edu.
Devin KoestlerGeisel School of Medicine at Dartmouth, 1 Rope Ferry Road, Hanover, NH 03755, USA. Electronic address: Devin.C.Koestler@Dartmouth.edu.
David RobbinsUniversity of Miami, Miller School of Medicine, 1600 NW 10th Ave #1140, Miami, FL 33136, USA. Electronic address: drobbins@med.miami.edu.
Dennis Liang FeiUniversity of Miami, Miller School of Medicine, 1600 NW 10th Ave #1140, Miami, FL 33136, USA. Electronic address: dlfei@med.miami.edu.
Meena MalipatlollaInstitute for Immunity, Transplantation, and Infection, Stanford University, 299 Campus Drive, Stanford, CA 94305, USA.
Holden MaeckerInstitute for Immunity, Transplantation, and Infection, Stanford University, 299 Campus Drive, Stanford, CA 94305, USA.
Richard EnelowGeisel School of Medicine at Dartmouth, 1 Rope Ferry Road, Hanover, NH 03755, USA. Electronic address: Richard.I.Enelow@Dartmouth.edu.
Susan KorrickBrigham and Women's Hospital, Department of Medicine, Channing Division of Network Medicine, Harvard Medical School, 181 Longwood Ave, Boston, MA 02115, USA; Harvard School of Public Health, Department of Environmental Health, 677 Huntington Ave, Boston, MA 02115, USA. Electronic address: susan.korrick@channing.harvard.edu.
Margaret R KaragasGeisel School of Medicine at Dartmouth, 1 Rope Ferry Road, Hanover, NH 03755, USA. Electronic address: Margaret.R.Karagas@Dartmouth.edu.
Dartmouth College · USStanford University · USUniversity of Miami · USBrigham and Women's Hospital · US

Funding

Translational Engineering in Cancer (TEC)P30CA023108 · NCI · DARTMOUTH COLLEGE · PI Steven D Leach · 1985 to 2026
$91.3M
VARIATION IN BIOACCUMULATION AND BIOMAGNIFICATION OF METALS IN NORTHERN US LAKESP42ES007373 · NIEHS · DARTMOUTH COLLEGE · PI CHEN, CELIA Y · 1995 to 2019
$52.0M
SEAL (Stopping Atopic dermatitis and ALlergy) Study: Prevent allergy by enhancing the skin barrierU01AI147462 · NIAID · STANFORD UNIVERSITY · PI Mary Johnson, GIDEON LACK · 2020 to 2026
$14.0M
Project 3: Placental Biomarkers of Exposure and Outcome (Marsit)P01ES022832 · NIEHS · DARTMOUTH COLLEGE · PI MURRAY, CAROLYN J · 2013 to 2018
$4.7M
Training Program for Quantitative Population Sciences in CancerR25CA134286 · NCI · DARTMOUTH COLLEGE · PI KARAGAS, MARGARET RITA, TOSTESON, TOR D · 2009 to 2018
$3.0M
Arsenic and T cell function: an Environment Maternal/child Immunity StudyR21ES020936 · NIEHS · DARTMOUTH COLLEGE · PI KARAGAS, MARGARET RITA, NADEAU, KARI C. · 2012 to 2013
$450k
NCI NIH HHS P30 CA023108NCI NIH HHS R25 CA134286NIAID NIH HHS U01 AI147462NIEHS NIH HHS P01 ES022832NIEHS NIH HHS P42 ES007373NIEHS NIH HHS R21 ES020936
6 · The paper itself

Abstract

Arsenic has wide-ranging effects on human health and there is evidence that it alters the immune response by influencing CD4+/CD8+ T cell ratios, IL-2 cytokine levels, and the expression of immune-response genes. We investigated the impact of in utero environmental arsenic exposure on immune development and function in newborns participating in a pregnancy cohort in New Hampshire, U.S., where arsenic levels have exceeded the current EPA maximum contaminant level of 10 μg/L. Our results showed that maternal urinary arsenic concentrations were inversely related to absolute total CD45RA+ CD4+ cord blood CD69+ T cell counts (N=116, p=0.04) and positively associated with CD45RA+ CD69- CD294+ cell counts (p=0.01). In placental samples (N=70), higher in utero urinary arsenic concentrations were positively associated with the expression of IL1β (p=0.03). These data provide evidence that relatively low-level arsenic exposure in utero may alter the fetal immune system and lead to immune dysregulation.

Indexed as

AdultArsenicFemaleFetal BloodGene ExpressionHumansImmune SystemImmunophenotypingInfant, NewbornInterleukin-1betaLymphocyte ActivationMaleMaternal ExposureNew HampshirePhenotypePlacentaArsenicInterleukin-1betaAQP9ArsenicIL1βImmune functionIn uteroT cell

Identifiers

PMID25229165
PMCPMC4309995
OpenAlexW1966402929

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.